United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report

United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report

Summary

United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key HighlightsUnited Therapeutics Corporation (United Therapeutics or 'the company') is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The product portfolio of the company includes Remodulin injection; Tyvaso (treprostinil) inhalation solution; Adcirca (tadalafil) tablets; Unituxin (dinutuximab) injection, and Orenitram (treprostinil) extended release tablets. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents, and cell-based therapies. United Therapeutics sells products through specialty pharmaceutical distributors in the US. United Therapeutics operates in Europe, Israel and the Middle East, Asia and South and Central America. The company is headquartered in Silver Spring, Maryland, the US.ScopeDetailed information on United Therapeutics Corporation required for business and competitor intelligence needsA study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysisAn in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segmentsIntelligence on United Therapeutics Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisorsNews about United Therapeutics Corporation, such as business expansion, restructuring, and contract winsLarge number of easy-to-grasp charts and graphs that present important data and key trendsReaasons to BuyGain understanding of United Therapeutics Corporation and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.Assess United Therapeutics Corporation as a prospective partner, vendor or supplier.Support sales activities by understanding your customers' businesses better.Stay up to date on United Therapeutics Corporation's business structure, strategy and prospects.